In vitro dose-dependent effects of enrofloxacin on equine articular cartilage.

The study investigates the impact of varying doses of enrofloxacin, a commonly used antimicrobial, on the health of horse joint tissue. The findings reveal that while low doses do not harm the cartilage, high concentrations can be toxic.

Research Methodology

• Cartilage samples were taken from 6 healthy horses of different ages, ranging from 0 to 96 months.
• The cartilage was then exposed to 5 different concentrations of enrofloxacin for 72 hours.
• The research team measured proteoglycan synthesis and degradation, endogenous proteoglycan content, and total protein content. This helped them understand the effect of the antibiotic on the cartilage’s metabolic activities.
• The researchers used histomorphologic and histomorphometric techniques to evaluate the cartilage samples.
• The quantitative data were analyzed with a one-way ANOVA and a general linear model to compare the effects of the different drug doses and understand whether the age of the horse affects the outcomes.

Research Findings

• Proteoglycan synthesis, a crucial process for cartilage health, was found to be excellent in control specimens and in those treated with low concentrations of enrofloxacin.
• High concentrations of the drug, however, eliminated proteoglycan synthesis regardless of the age of the horse.
• Similarly, proteoglycan degradation did not occur at low drug concentrations but was significant at higher concentrations.
• The antibiotic concentrations used didn’t affect the endogenous proteoglycan content.
• At high concentrations, the drug significantly increased the number of pyknotic nuclei, indicator of cell death.

Conclusion

The study concludes that doses of enrofloxacin that could be achieved through systemic administration do not suppress the metabolic activities of chondrocyte, the only cells found in healthy cartilage. However, high doses of the drug proved toxic to these cells. This suggests a need for caution when administering higher doses of enrofloxacin to horses, as it could potentially harm joint health.